Safeguarding cancer research funding by European charities amidst the COVID-19 pandemic.

The COVID-19 outbreak has affected cancer research and cancer care. European cancer charities need to reconsider strategies for safeguarding income and supporting cancer researchers, in times when sustaining cancer research funding is more crucial than ever.

A Comparison of Online Medical Crowdfunding in Canada, the UK, and the US.

Importance: Despite major differences in their health care systems, medical crowdfunding is increasingly used to finance personal health care costs in Canada, the UK, and the US. However, little is known about the campaigns designed to raise monetary donations for medical expenses, the individuals who turn to crowdfunding, and their fundraising intent. Objective: To examine the demographic characteristics of medical crowdfunding beneficiaries, campaign characteristics, and their association with funding success in Canada, the UK, and the US. Design, Setting, and Participants: This cross-sectional study extracted and manually reviewed data from GoFundMe campaigns discoverable between February 2018 and March 2019. All available campaigns on each country domain's GoFundMe medical discovery webpage that benefitted a unique patient(s) were included from Canada, the UK, and the US. Data analysis was performed from March to December 2019. Exposures: Campaign and beneficiary characteristics. Main Outcomes and Measures: Log-transformed amount raised in US dollars. Results: This study examined 3396 campaigns including 1091 in Canada, 1082 in the UK, and 1223 in the US. Campaigns in the US (median [IQR], $38 204 [$31 200 to $52 123]) raised more funds than campaigns in Canada ($12 662 [$9377 to $19 251]) and the UK ($6285 [$4028 to $12 348]). In the overall cohort per campaign, Black individuals raised 11.5% less (95% CI, -19.0% to -3.2%; P = .006) than non-Black individuals, and male individuals raised 5.9% more (95% CI, 2.2% to 9.7%; P = .002) than female individuals. Female (39.4% of campaigns vs 50.8% of US population; difference, 11.3%; 95% CI, 8.6% to 14.1%; P < .001) and Black (5.3% of campaigns vs 13.4% of US population; difference, 8.1%; 95% CI, 6.8% to 9.3%; P < .001) beneficiaries were underrepresented among US campaigns. Campaigns primarily for routine treatment expenses were approximately 3 times more common in the US (77.9% [272 of 349 campaigns]) than in Canada (21.9% [55 of 251 campaigns]; difference, 56.0%; 95% CI, 49.3-62.7%; P < .001) or the UK (26.6% [127 of 478 campaigns]; difference, 51.4%; 95% CI, 45.5%-57.3%; P < .001). However, campaigns for routine care were less successful overall. Approved, inaccessible care and experimental care raised 35.7% (95% CI, 25.6% to 46.7%; P < .001) and 20.9% (95% CI, 13.3% to 29.1%; P < .001), respectively, more per campaign than routine care. Campaigns primarily for alternative treatment expenses (16.1% [174 of 1079 campaigns]) were nearly 4-fold more common for cancer (23.5% [144 of 614 campaigns]) vs noncancer (6.5% [30 of 465 campaigns]) diagnoses. Conclusions and Relevance: Important differences were observed in the reasons individuals turn to medical crowdfunding in the 3 countries examined that suggest racial and gender disparities in fundraising success. More work is needed to understand the underpinnings of these findings and their implications on health care provision in the countries examined.

Popular honorees, classic appeal contribute to fund raising success. UPHC leadership dinner grows every year.

University of Pittsburgh Cancer Institute ran its ninth annual Leadership Dinner with record-high results: $522,115. Every year, invitations use a traditional design incorporating the university's venerable 1787 logo. The event receives a boost from an internal awards event for hospital staffers, held the day prior to the dinner. In the two past years, the dinner was recognized by the Pittsburgh Post-Gazette as the "Best Awards Dinner" in the area.

Normas directrices para donantes y beneficiarios de donaciones farmaceuticas / Standards for donors and recipients of pharmaceutical donations

La experiencia nos demuestra que todavia existen demasiados ejemplos de donaciones de productos farmaceuticos que en lugar de ser utiles han causado problemas, siendo las razones mas comunes para que el donante tiene el deseo y la voluntad de hacer algo util pero no sabe como realizar todos los tramites. La donacion se realiza para beneficiar al donante. Los beneficiarios no comunican lo suficientemente clara sus necesidades, por lo que necesitamos normas directrices para donantes y beneficiarios de donaciones farmaceuticas

Directrices relacionadas con las donaciones de equipo y material / Directrix related with donations of equipment and material

Esta guia, destinada tanto a los que reciben como a los que hacen donaciones puede ser util tambien para los que proyectan adquirir equipo y material